{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:01:10Z","timestamp":1790845270057,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T00:00:00Z","timestamp":1591833600000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cbi.2019.05.051","type":"journal-article","created":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T23:14:39Z","timestamp":1559171679000},"page":"372-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds"],"prefix":"10.1016","volume":"308","author":[{"given":"Shuo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxia","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Guo","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2019.05.051_bib1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/539156a","article-title":"How to defeat dementia","volume":"539","author":"Dolgin","year":"2016","journal-title":"Nature News"},{"key":"10.1016\/j.cbi.2019.05.051_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj2600625","article-title":"Comparison of butyrylcholinesterase and acetylcholinesterase","volume":"260","author":"Chatonnet","year":"1989","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.05.051_bib3","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.107.133330","article-title":"The butyrylcholinesterase knockout mouse as a model for human butyrylcholinesterase deficiency","volume":"324","author":"Li","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.cbi.2019.05.051_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2006.11.005","article-title":"A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India","volume":"378","author":"Manoharan","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cbi.2019.05.051_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1185\/03007990152673800","article-title":"A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase","volume":"17","author":"Greig","year":"2001","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.cbi.2019.05.051_bib6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.cbi.2019.05.051_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer's disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.cbi.2019.05.051_bib8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2174\/156720512799015127","article-title":"Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex","volume":"9","author":"Ciro","year":"2012","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.cbi.2019.05.051_bib9","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cbi.2019.05.051_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","article-title":"Changes in brain cholinesterases in senile dementia of Alzheimer type","volume":"4","author":"PERRY","year":"1978","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cbi.2019.05.051_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"308","author":"Davies","year":"1976","journal-title":"The Lancet"},{"key":"10.1016\/j.cbi.2019.05.051_bib12","doi-asserted-by":"crossref","first-page":"39495","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Kosak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.05.051_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bbr.2011.07.035","article-title":"Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-\u03b2 peptide in mice","volume":"225","author":"Furukawa-Hibi","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2019.05.051_bib14","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1471-4159.2006.04347.x","article-title":"Excessive hippocampal acetylcholine levels in acetylcholinesterase\u2010deficient mice are moderated by butyrylcholinesterase activity","volume":"100","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2019.05.051_bib15","first-page":"17223","article-title":"Blocking drug activation as a therapeutic strategy to attenuate acute toxicity and physiological effects of heroin","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2019.05.051_bib16","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1016\/j.bmcl.2006.08.067","article-title":"6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors","volume":"16","author":"Schott","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ejmech.2004.12.003","article-title":"Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine","volume":"40","author":"Decker","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib18","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm049011j","article-title":"Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases","volume":"48","author":"Wadkins","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1021\/np300628a","article-title":"Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza (\"Danshen\")","volume":"76","author":"Hatfield","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.cbi.2019.05.051_bib20","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1021\/jm00127a020","article-title":"Binary antidotes for organophosphate poisoning: aprophen analogues that are both antimuscarinics and carbamates","volume":"32","author":"Leader","year":"1989","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib21","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.bmc.2007.03.012","article-title":"Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils","volume":"15","author":"Hicks","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib22","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1021\/jm0309194","article-title":"Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from Sarcococca saligna","volume":"46","author":"Zaheer-Ul-Haq","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib23","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1021\/jm061471k","article-title":"Selective inhibition of carboxylesterases by isatins, indole-2,3-diones","volume":"50","author":"Hyatt","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bmc.2005.10.044","article-title":"Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase","volume":"14","author":"Decker","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0960-894X(01)00294-3","article-title":"Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase","volume":"11","author":"Savini","year":"2001","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib26","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.bmc.2010.01.066","article-title":"Differential binding of phenothiazine urea derivatives to wild-type human cholinesterases and butyrylcholinesterase mutants","volume":"18","author":"Darvesh","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib27","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1021\/jm0706867","article-title":"Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1","volume":"50","author":"Hyatt","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm0255668","article-title":"Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors","volume":"46","author":"Savini","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jm701491k","article-title":"Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates","volume":"51","author":"Fang","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib30","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1021\/jm060682m","article-title":"Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase","volume":"49","author":"Decker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib31","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1016\/j.bmcl.2008.08.076","article-title":"Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity","volume":"18","author":"Butini","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib32","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1021\/jm060257t","article-title":"Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites","volume":"49","author":"Gemma","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib33","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1021\/jm00222a016","article-title":"Potent reversible anticholinesterase agents. Bis- and mono-N-substituted benzoquinolinium halides","volume":"20","author":"Chen","year":"1977","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib34","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Abeta aggregation, and beta-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib35","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.bmc.2012.09.016","article-title":"Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Abeta aggregation, and beta-secretase","volume":"20","author":"Peng","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib36","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/S0960-894X(03)00599-7","article-title":"Cage amines as the stopper inhibitors of cholinesterases","volume":"13","author":"Lin","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib37","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/14756360600889708","article-title":"New natural cholinesterase inhibiting and calcium channel blocking quinoline alkaloids","volume":"21","author":"Atta ur","year":"2006","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib38","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1021\/jm8002075","article-title":"Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase","volume":"51","author":"Darvesh","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1747-0285.2012.01435.x","article-title":"Synthesis and biological evaluation of 3-thiazolocoumarinyl Schiff-base derivatives as cholinesterase inhibitors","volume":"80","author":"Raza","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2019.05.051_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bmcl.2010.11.051","article-title":"Preparation, in vitro screening and molecular modelling of symmetrical 4-tert-butylpyridinium cholinesterase inhibitors--analogues of SAD-128","volume":"21","author":"Musilek","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib41","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm701253t","article-title":"Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors","volume":"51","author":"Butini","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib42","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/S0960-894X(98)00484-3","article-title":"Conformationally restricted carbamate inhibitors of horse serum butyrylcholinesterase","volume":"8","author":"Lin","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2019.05.051_bib43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1021\/jm00376a006","article-title":"N-allyl analogues of phencyclidine: chemical synthesis and pharmacological properties","volume":"27","author":"Kalir","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/jm049309+","article-title":"Novel anticholinesterases based on the molecular skeletons of furobenzofuran and methanobenzodioxepine","volume":"48","author":"Luo","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib45","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib46","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1016\/j.bmc.2016.07.025","article-title":"Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer's disease based on the fusion of donepezil and melatonin","volume":"24","author":"Wang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF03401927","article-title":"Clioquinol-zinc chelate: a candidate causative agent of subacute myelo-optic neuropathy","volume":"4","author":"Arbiser","year":"1998","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2019.05.051_bib48","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cmdc.201600014","article-title":"Novel 8-hydroxyquinoline derivatives as multitarget compounds for the treatment of Alzheimer's disease","volume":"11","author":"Prati","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbi.2019.05.051_bib49","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bmc.2016.01.031","article-title":"Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors","volume":"24","author":"Makhaeva","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib50","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0968-0896(98)00213-2","article-title":"Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis","volume":"7","author":"Carlier","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib51","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.bmc.2014.08.035","article-title":"Design, synthesis and evaluation of novel tacrine-(\u03b2-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"22","author":"Lan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0090-9556(25)07050-3","article-title":"Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood","volume":"16","author":"Tunek","year":"1988","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.05.051_bib53","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2165\/00003088-199631040-00002","article-title":"Clinical pharmacokinetics of bambuterol","volume":"31","author":"Sitar","year":"1996","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2019.05.051_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1124\/dmd.114.060251","article-title":"Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates","volume":"43","author":"Pistolozzi","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2019.05.051_bib55","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1080\/14756366.2017.1368019","article-title":"Synthesis and biological evaluation of aminomethyl and alkoxymethyl derivatives as carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase inhibitors","volume":"32","author":"Gul\u00e7in","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity","volume":"61","author":"Ko\u0161ak","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib57","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure\u2013activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib58","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/aps.2012.21","article-title":"Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors","volume":"33","author":"Sakkiah","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2019.05.051_bib59","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/acs.jcim.5b00136","article-title":"LiSiCA: a software for ligand-based virtual screening and its application for the discovery of butyrylcholinesterase inhibitors","volume":"55","author":"Le\u0161nik","year":"2015","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.cbi.2019.05.051_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl-and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2019.05.051_bib61","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib63","series-title":"The PyMOL Molecular Graphics System, Version 2.0","author":"Schr\u00f6dinger","year":"2018"},{"key":"10.1016\/j.cbi.2019.05.051_bib64","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.1039\/c3ob41713a","article-title":"Substrate selectivity of high-activity mutants of human butyrylcholinesterase","volume":"11","author":"Hou","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.cbi.2019.05.051_bib65","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/S0031-9422(00)98055-5","article-title":"The acetylcholinesterase-inhibitory activity of steroidal glycoalkaloids and their aglycones","volume":"28","author":"Roddick","year":"1989","journal-title":"Phytochemistry"},{"key":"10.1016\/j.cbi.2019.05.051_bib66","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1124\/mol.104.009944","article-title":"The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic action","volume":"67","author":"Harel","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2019.05.051_bib67","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1021\/bi020151+","article-title":"X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (\u2212)-huperzine B: structural evidence for an active site rearrangement","volume":"41","author":"Dvir","year":"2002","journal-title":"Biochemistry"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279719303540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:00:12Z","timestamp":1757858412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279719303540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":67,"alternative-id":["S0009279719303540"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.051","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2019.05.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}